India's Venus Remedies up 11% on marketing approval for cancer drug

Venus Remedies

09/05/2023 06:34

** Shares of Venus Remedies Ltd  VENR.NS  rise as much as
10.7% to 215 rupees
    ** Research and pharmaceutical firm says it has secured
marketing authorisation for two widely used cancer drugs from
Philippines and Iraq
    ** If trend holds, stock on track to advance for second
consecutive session
    ** About 122,854 shares change hands by 10:46 a.m. IST, 1.8x
the 30-day avg - Refinitiv Data
    ** Stock last up 8.3%, extending YTD gains to 16.1%

 (Reporting by Priya Sagar in Bengaluru)
 ((Priya.Sagar@thomsonreuters.com))